Histiocytic medullary reticulosis

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

EJHaem·2023

Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.

Mycoses·2018

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.

Annals of hematology·2018

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Annals of oncology : official journal of the European Society for Medical Oncology·2016

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Leukemia·2016

Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.

Leukemia·2015

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

[Cloning of Mycoplasma gallisepticum Genome in Saccharomyces cerevisiae Cells].

Molekuliarnaia biologiia·2026

Rapid PCR-based diagnosis of superficial mycoses with ROC-optimized cutoffs.

Microbiology spectrum·2026

The Return of a Rare Entity: Recurrent Neck Rhabdomyoma.

The Journal of craniofacial surgery·2026

Mr BMT Achieves Systemic Macrophage Replacement With Preservation of Tissue Homeostasis.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Disseminated Histoplasmosis Masquerading as Metastatic Malignancy: A Diagnostic Odyssey in an Immunocompromised Host.

Cureus·2026

Primary Tuberculous Osteomyelitis of the Proximal Tibia Presenting as Chronic Osteomyelitis: A Diagnostic Challenge in Musculoskeletal Tuberculosis.

Journal of orthopaedic case reports·2026

Related Experiment Videos

Histiocytic medullary reticulosis

Related Concept Videos

FLT3-targeted therapy restores GATA1 pathway function in NPM1/FLT3-ITD mutated acute myeloid leukaemia.

Fungal infections of the central nervous system and paranasal sinuses in onco-haematologic patients. Epidemiological study reporting the diagnostic-therapeutic approach and outcome in 89 cases.

Bloodstream infections in haematological cancer patients colonized by multidrug-resistant bacteria.

Preference for subcutaneous or intravenous administration of rituximab among patients with untreated CD20+ diffuse large B-cell lymphoma or follicular lymphoma: results from a prospective, randomized, open-label, crossover study (PrefMab).

Galectin-1 suppression delineates a new strategy to inhibit myeloma-induced angiogenesis and tumoral growth in vivo.

Osteolytic lesions, cytogenetic features and bone marrow levels of cytokines and chemokines in multiple myeloma patients: Role of chemokine (C-C motif) ligand 20.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

[Cloning of Mycoplasma gallisepticum Genome in Saccharomyces cerevisiae Cells].

Rapid PCR-based diagnosis of superficial mycoses with ROC-optimized cutoffs.

The Return of a Rare Entity: Recurrent Neck Rhabdomyoma.

Mr BMT Achieves Systemic Macrophage Replacement With Preservation of Tissue Homeostasis.

Disseminated Histoplasmosis Masquerading as Metastatic Malignancy: A Diagnostic Odyssey in an Immunocompromised Host.

Primary Tuberculous Osteomyelitis of the Proximal Tibia Presenting as Chronic Osteomyelitis: A Diagnostic Challenge in Musculoskeletal Tuberculosis.

Related Experiment Videos

Histiocytic medullary reticulosis

Related Concept Videos

Related Articles